P055: Immunological cross-reactivity of anti-drug antibodies to adalimumab and ABP 501ECCO '18 Vienna
2018
P056: South Asian ethnicity drives differences in microbial and metabolic profiling in a newly diagnosed ulcerative colitis cohortECCO '18 Vienna
2018
P057: Proteomic analysis highlights divergences and convergences between ileal and colonic pathological processes involved in Crohn’s ulcersECCO '18 Vienna
2018
P058: Phosphodiesterase 8A domains at the site of leucocyte–endothelial cell adhesion in ulcerative colitis submucosaECCO '18 Vienna
2018
P060: Post-inflammatory visceral pain induced by DNBS: Preclinical features for novel therapeuticsECCO '18 Vienna
2018
P062: Small intestinal lactulose and sucralose hyper-permeability in inflammatory bowel diseaseECCO '18 Vienna
2018
P063: Faecal calprotectin as a non-invasive treatment target to predict mucosal healing and histological remission in asymptomatic ulcerative colitisECCO '18 Vienna
2018
P064: Intestinal expression of LAG-3 correlates with inflammatory activity and response to biological therapy in ulcerative colitisECCO '18 Vienna
2018
P065: REDD1/autophagy-driven NETosis promotes IL-1β-mediated inflammation in active ulcerative colitisECCO '18 Vienna
2018
P066: Pharmacologic inhibition of integrin αvβ6 causes tumour shrinkage in colitis associated mouse colon tumoursECCO '18 Vienna
2018
P067: Proliferating intestinal macrophage populations in human inflammatory bowel diseaseECCO '18 Vienna
2018
P068: Loss of PTPN22 abrogates the beneficial effect of faecal microbiota transferECCO '18 Vienna
2018
P070: Mucosal immune signature in IBD: To what extent α4β7-expressing peripheral T cells reflect T-lymphocyte population resident in gut mucosa?ECCO '18 Vienna
2018
P071: Cancer preventive effect of recombinant TRAIL by ablation of oncogenic inflammation in colitis-associated cancer rather than anticancer effectECCO '18 Vienna
2018